Seasonal Affective Disorder: A Guide to Diagnosis and Management.
Saved in:
| Title: | Seasonal Affective Disorder: A Guide to Diagnosis and Management. |
|---|---|
| Authors: | Partonen, T., Lönnqvist, J. |
| Source: | CNS Drugs. 1998, Vol. 9 Issue 3, p203-212. 10p. |
| Subjects: | Seasonal affective disorder, Phototherapy, Diagnosis |
| Abstract: | Seasonal affective disorder (SAD) is characterised by recurrent depressive episodes, occurring typically in winter (i.e. winter SAD). The atypical symptoms of depression frequently precede the onset of each episode and are closely associated with the recurrence of the episodes. Winter depressive episodes are mostly of mild to moderate severity. Patients with winter SAD seldom require hospitalisation, have psychotic symptoms or are at risk of suicide. However, most patients do experience marked impairment of functioning at work and in their social relations. Light therapy is the treatment of choice for patients with winter SAD. Treatment with bright light in the morning results in remission in two-thirds of patients with mild episodes, but in less than half of those with moderate to severe episodes. The clinical response to the daily administration of light is usually observed within 1 to 2 weeks of the onset of this treatment. The presence of atypical symptoms of depression, rather than the severity of the episode, best predict a therapeutic response to light therapy. It is recommended that therapy be continued throughout the winter to prevent relapse and optimise outcome. Preliminary data from controlled trials indicate that drug treatment may also be effective in patients with winter SAD. Current data suggest efficacy for the selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors fluoxetine and sertraline, and the reversible inhibitor of monoamine oxidase A moclobemide. There are no studies on the efficacy of psychological therapies in these patients. Comorbid disorders frequently influence the clinical picture in patients with SAD by modulating the course of illness, and each may require specific intervention. [ABSTRACT FROM AUTHOR] |
| Copyright of CNS Drugs is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 9523399 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Seasonal Affective Disorder: A Guide to Diagnosis and Management. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Partonen%2C+T%2E%22">Partonen, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Lönnqvist%2C+J%2E%22">Lönnqvist, J.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22CNS+Drugs%22">CNS Drugs</searchLink>. 1998, Vol. 9 Issue 3, p203-212. 10p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Seasonal+affective+disorder%22">Seasonal affective disorder</searchLink><br /><searchLink fieldCode="DE" term="%22Phototherapy%22">Phototherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Diagnosis%22">Diagnosis</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Seasonal affective disorder (SAD) is characterised by recurrent depressive episodes, occurring typically in winter (i.e. winter SAD). The atypical symptoms of depression frequently precede the onset of each episode and are closely associated with the recurrence of the episodes. Winter depressive episodes are mostly of mild to moderate severity. Patients with winter SAD seldom require hospitalisation, have psychotic symptoms or are at risk of suicide. However, most patients do experience marked impairment of functioning at work and in their social relations. Light therapy is the treatment of choice for patients with winter SAD. Treatment with bright light in the morning results in remission in two-thirds of patients with mild episodes, but in less than half of those with moderate to severe episodes. The clinical response to the daily administration of light is usually observed within 1 to 2 weeks of the onset of this treatment. The presence of atypical symptoms of depression, rather than the severity of the episode, best predict a therapeutic response to light therapy. It is recommended that therapy be continued throughout the winter to prevent relapse and optimise outcome. Preliminary data from controlled trials indicate that drug treatment may also be effective in patients with winter SAD. Current data suggest efficacy for the selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors fluoxetine and sertraline, and the reversible inhibitor of monoamine oxidase A moclobemide. There are no studies on the efficacy of psychological therapies in these patients. Comorbid disorders frequently influence the clinical picture in patients with SAD by modulating the course of illness, and each may require specific intervention. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of CNS Drugs is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=9523399 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2165/00023210-199809030-00004 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 203 Subjects: – SubjectFull: Seasonal affective disorder Type: general – SubjectFull: Phototherapy Type: general – SubjectFull: Diagnosis Type: general Titles: – TitleFull: Seasonal Affective Disorder: A Guide to Diagnosis and Management. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Partonen, T. – PersonEntity: Name: NameFull: Lönnqvist, J. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 1998 Type: published Y: 1998 Identifiers: – Type: issn-print Value: 11727047 Numbering: – Type: volume Value: 9 – Type: issue Value: 3 Titles: – TitleFull: CNS Drugs Type: main |
| ResultId | 1 |
